Platelet-rich plasma for osteoarthritis treatment

Eduardo Knop, Luiz Eduardo de Paula, Ricardo Fuller
2016 Revista Brasileira de Reumatologia (English Edition)  
We conducted a comprehensive and systematic search of the literature on the use of plateletrich plasma (PRP) in the treatment of osteoarthritis, using the Medline, Lilacs, Cochrane and SciELO databases, from May 2012 to October 2013. A total of 23 studies were selected, with nine being controlled trials and, of these, seven randomized, which included 725 patients. In this series, the group receiving PRP showed improvement in pain and joint function compared to placebo and hyaluronic acid. The
more » ... sponse lasted up to two years and was better in milder cases. However it was found that there is no standardization in the PRP production method, neither in the number, timing, and volume of applications. Furthermore, the populations studied were not clearly described in many studies. Thus, these results should be analyzed with caution, and further studies with more standardized methods would be necessary for a more consistent conclusion about the PRP role in osteoarthritis.
doi:10.1016/j.rbre.2015.07.002 pmid:27267529 fatcat:qohh3n4dwjb57baaq6tipddfba